Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Leukemia, Myeloid, Acute 20Lymphoma, Non-Hodgkin 14Congenital Abnormalities 14Multiple Myeloma 13Leukemia, Lymphocytic, Chronic, B-Cell 11Leukemia 11Myelodysplastic Syndromes 10Lymphoma, Mantle-Cell 9Hodgkin Disease 9Lymphoma, Large B-Cell, Diffuse 8Lymphoma 8Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Myeloid, Accelerated Phase 7Waldenstrom Macroglobulinemia 6Anemia, Refractory, with Excess of Blasts 6Sezary Syndrome 5Recurrence 5Myeloproliferative Disorders 5Mycosis Fungoides 5Lymphoma, T-Cell, Cutaneous 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Graft vs Host Disease 5Burkitt Lymphoma 5Lymphoma, Extranodal NK-T-Cell 4Leukemia, Myelomonocytic, Juvenile 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4

Interventions

Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × High Risk Hematologic Malignancy × Transplantation × Clear all
NCT03913026 2025-10-27

UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia

Ciusss de L'Est de l'Île de Montréal

Phase 2 Active not recruiting
30 enrolled

High Risk Hematologic Malignancy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡